In a statement sent to reporters, the ARTA disclosed that it recommended 412 counts of failure to render government services within the prescribed processing time against FDA Center for Drug Regulation and Research Director Jesusa Joyce Cirunay. “Cursory perusal of Respondent Director Cirunay’s attachment in both her Letters would show that there has been delay in the processing of the Four Hundred and Twelve (412) applications,” the ARTA’s Disposition read. RELATED: FDA to cooperate with anti-red tape body on delays in drug applicationsWhat happened? To recall, the ARTA accused the department of "sitting on" AR drug applications after 23 affidavits of pharmaceutical firms complained of delays in the processing of their applications filed as far back as 2014. However, its validation with the Philippine Chamber of Pharmaceutical Industry, Inc. disclosed that there are still eight remaining AR applications awaiting action, the ARTA said.

Source: Philippine Star June 09, 2021 06:11 UTC